Literature DB >> 21356220

Modeling treatment-resistant depression.

Benjamin Adam Samuels1, Eduardo David Leonardo, Reto Gadient, Amanda Williams, Jin Zhou, Denis J David, Alain Michel Gardier, Erik H F Wong, René Hen.   

Abstract

Depression is a polygenic and highly complex psychiatric disorder that is currently a major burden on society. Depression is highly heterogeneous in presentation and frequently exhibits high comorbidity with other psychiatric and somatic disorders. Commonly used treatments, such as selective serotonin reuptake inhibitors (SSRIs), are not ideal since only a subset of patients achieve remission. In addition, the reason why some individuals respond to SSRIs while others don't are unknown. Here we begin to ask what the basis of treatment resistance is, and propose new strategies to model this phenomenon in animals. We focus specifically on animal models that offer the appropriate framework to study treatment resistance with face, construct and predictive validity. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356220      PMCID: PMC3110541          DOI: 10.1016/j.neuropharm.2011.02.017

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  67 in total

Review 1.  Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.

Authors:  A M Gardier; I Malagié; A C Trillat; C Jacquot; F Artigas
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

2.  Animal models of depression: molecular perspectives.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Curr Top Behav Neurosci       Date:  2011

Review 3.  Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

Authors:  F Artigas; L Romero; C de Montigny; P Blier
Journal:  Trends Neurosci       Date:  1996-09       Impact factor: 13.837

4.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.

Authors:  F Artigas; V Perez; E Alvarez
Journal:  Arch Gen Psychiatry       Date:  1994-03

5.  Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders.

Authors:  Andreas Hahn; Rupert Lanzenberger; Wolfgang Wadsak; Christoph Spindelegger; Uirike Moser; Leonhard-Key Mien; Markus Mitterhauser; Siegfried Kasper
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

6.  5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.

Authors:  Amélie Lothe; Claudette Boni; Nicolas Costes; Sandrine Bouvard; Philip Gorwood; Franck Lavenne; Marion Alvarez; Philippe Ryvlin
Journal:  Behav Brain Funct       Date:  2010-07-07       Impact factor: 3.759

7.  Susceptibility and resistance of rats to stress-induced decreases in swim-test activity: a selective breeding study.

Authors:  P A Scott; M A Cierpial; C D Kilts; J M Weiss
Journal:  Brain Res       Date:  1996-07-01       Impact factor: 3.252

8.  Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression.

Authors:  Shannon L Gourley; Florence J Wu; Drew D Kiraly; Jonathan E Ploski; Alexia T Kedves; Ronald S Duman; Jane R Taylor
Journal:  Biol Psychiatry       Date:  2007-09-24       Impact factor: 13.382

Review 9.  Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges.

Authors:  Erik H F Wong; Sham S Nikam; Mohammed Shahid
Journal:  Curr Opin Investig Drugs       Date:  2008-01

Review 10.  Rats selectively-bred for behavior related to affective disorders: proclivity for intake of alcohol and drugs of abuse, and measures of brain monoamines.

Authors:  J M Weiss; C H K West; M S Emery; R W Bonsall; J P Moore; K A Boss-Williams
Journal:  Biochem Pharmacol       Date:  2007-10-06       Impact factor: 5.858

View more
  29 in total

1.  Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats.

Authors:  Nick Van Laeken; Glenn Pauwelyn; Robrecht Dockx; Benedicte Descamps; Boudewijn Brans; Kathelijne Peremans; Chris Baeken; Ingeborg Goethals; Christian Vanhove; Filip De Vos
Journal:  J Neural Transm (Vienna)       Date:  2018-06-28       Impact factor: 3.575

2.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

Review 3.  5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function.

Authors:  Alvaro L Garcia-Garcia; Adrian Newman-Tancredi; E David Leonardo
Journal:  Psychopharmacology (Berl)       Date:  2013-12-12       Impact factor: 4.530

4.  Chronic corticosterone shifts effort-related choice behavior in male mice.

Authors:  Andrew Dieterich; Karina Stech; Prachi Srivastava; Jay Lee; Aitesam Sharif; Benjamin Adam Samuels
Journal:  Psychopharmacology (Berl)       Date:  2020-04-18       Impact factor: 4.530

Review 5.  Rodent models of treatment-resistant depression.

Authors:  Barbara J Caldarone; Venetia Zachariou; Sarah L King
Journal:  Eur J Pharmacol       Date:  2014-11-21       Impact factor: 4.432

6.  Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.

Authors:  Indira Mendez-David; Denis J David; Flavie Darcet; Melody V Wu; Saadia Kerdine-Römer; Alain M Gardier; René Hen
Journal:  Neuropsychopharmacology       Date:  2013-11-28       Impact factor: 7.853

Review 7.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

8.  Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; Catherine E Sykes; Dina M Francescutti; Donald M Kuhn
Journal:  ACS Chem Neurosci       Date:  2014-08-12       Impact factor: 4.418

9.  Utility of the Berlin questionnaire for predicting obstructive sleep apnea in individuals with treatment-resistant depression.

Authors:  Michael W Best; Michael Fitzpatrick; Roumen Milev; Christopher R Bowie; Ruzica Jokic
Journal:  Sleep Breath       Date:  2013-04-11       Impact factor: 2.816

10.  Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats.

Authors:  Bin Dong; Borehalli M Shilpa; Relish Shah; Arjun Goyal; Shan Xie; Mihran J Bakalian; Raymond F Suckow; Thomas B Cooper; J John Mann; Victoria Arango; K Yaragudri Vinod
Journal:  J Psychiatr Res       Date:  2019-10-11       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.